Form 4: Evolent Health Director Craig A. Barbarosh Increases Stake with Recent Stock Purchase

Director Craig A. Barbarosh of Evolent Health, Inc. recently acquired 2,000 shares of Class A Common Stock at a price of $8.81 per share.

Summary

• On March 6, 2025, Craig A. Barbarosh, a director of Evolent Health, Inc., purchased 2,000 shares of Class A Common Stock.
• The purchase price was $8.81 per share.
• Following the transaction, Barbarosh directly owns 31,956 shares of Evolent Health's Class A Common Stock, which includes restricted stock units granted under previous awards.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock purchase by a director. While insider buying can be seen as a positive signal, it's a single transaction and doesn't provide enough information to strongly indicate a positive outlook.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in a transaction involving the company's stock. It provides transparency to the market regarding the trading activities of those with privileged information.

Stakeholder Impact

• The stock purchase by a director could have a minor positive impact on shareholder sentiment.

Key Dates